Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications

被引:468
作者
Schmitt, Joern [1 ]
Duray, Gabor [1 ]
Gersh, Bernard J. [2 ]
Hohnloser, Stefan H. [1 ]
机构
[1] Goethe Univ Frankfurt, Div Cardiol, Sect Electrophysiol, D-60590 Frankfurt, Germany
[2] Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN USA
关键词
Atrial fibrillation; Acute myocardial infarction; Acute coronary syndrome; Anticoagulation; LEFT-VENTRICULAR DYSFUNCTION; CONGESTIVE-HEART-FAILURE; RENIN-ANGIOTENSIN SYSTEM; INTRAVENOUS AMIODARONE; ST-ELEVATION; CORONARY INTERVENTION; REPERFUSION THERAPY; CRITICALLY ILL; RISK; CARE;
D O I
10.1093/eurheartj/ehn579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF), the most commonly encountered clinical arrhythmia, often complicates acute myocardial infarction (AMI) with an incidence between 6 and 21%. Predictors of the arrhythmia in the setting of AMI include advanced age, heart failure symptoms, and depressed left ventricular function. The bulk of evidence demonstrates that AF in patients hospitalized for AMI has serious adverse prognostic implications regarding in-hospital, but also long-term mortality. This seems to apply for all patient populations studied without significant differences related to the treatment of AMI (i.e. no reperfusion therapy vs. thrombolysis vs. percutaneous coronary intervention). Mortality is particularly high in patients who have congestive heart failure and/or a reduced left ventricular ejection fraction. Finally, there are persuasive data indicating that AF complicating AMI not only increases the risk for ischaemic stroke during hospitalization but also during follow-up. This seems to apply also for transient AF which has reversed back to sinus rhythm at the time of discharge. These observations emphasize the need for prospective studies evaluating optimal therapeutic approaches for patients with AMI complicated by AF.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 56 条
[31]   Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAL experience [J].
Lehto, M ;
Snapinn, S ;
Dickstein, K ;
Swedberg, K ;
Nieminen, MS .
EUROPEAN HEART JOURNAL, 2005, 26 (04) :350-356
[32]   Atrial fibrillation in acute myocardial infarction: A prospective study based on data from a consecutive series of patients admitted to the coronary care unit [J].
Madias, JE ;
Patel, DC ;
Singh, D .
CLINICAL CARDIOLOGY, 1996, 19 (03) :180-186
[33]   Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial [J].
McMurray, J ;
Kober, L ;
Robertson, M ;
Dargie, H ;
Colucci, W ;
Lopez-Sendon, J ;
Remme, W ;
Sharpe, DN ;
Ford, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (04) :525-530
[34]   Mortality trends in patients diagnosed with first atrial fibrillation - A 21-year community-based study [J].
Miyasaka, Yoko ;
Barnes, Marion E. ;
Bailey, Kent R. ;
Cha, Stephen S. ;
Gersh, Bernard J. ;
Seward, James B. ;
Tsang, Teresa S. M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) :986-992
[35]   Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [J].
Miyasaka, Yoko ;
Barnes, Marion E. ;
Gersh, Bernard J. ;
Cha, Stephen S. ;
Bailey, Kent R. ;
Abhayaratna, Walter P. ;
Seward, James B. ;
Tsang, Teresa S. M. .
CIRCULATION, 2006, 114 (02) :119-125
[36]   REDUCED OCCURRENCE OF ATRIAL-FIBRILLATION IN ACUTE MYOCARDIAL-INFARCTION TREATED WITH STREPTOKINASE [J].
NIELSEN, FE ;
SORENSEN, HT ;
CHRISTENSEN, JH ;
RAVN, L ;
RASMUSSEN, SE .
EUROPEAN HEART JOURNAL, 1991, 12 (10) :1081-1083
[37]   The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction [J].
Pedersen, OD ;
Bagger, H ;
Kober, L ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 1999, 20 (10) :748-754
[38]   Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction [J].
Pedersen, OD ;
Abildstrom, SZ ;
Ottesen, MM ;
Rask-Madsen, C ;
Bagger, H ;
Kober, L ;
Torp-Pedersen, C .
EUROPEAN HEART JOURNAL, 2006, 27 (03) :290-295
[39]   Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction [J].
Pedersen, OD ;
Bagger, H ;
Kober, L ;
Torp-Pedersen, C .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (01) :65-71
[40]   Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design [J].
Pfeffer, MA ;
McMurray, J ;
Leizorovicz, A ;
Maggioni, AP ;
Rouleau, JL ;
Van de Werf, F ;
Henis, M ;
Neuhart, E ;
Gallo, P ;
Edwards, S ;
Sellers, MA ;
Velazquez, E ;
Califf, R .
AMERICAN HEART JOURNAL, 2000, 140 (05) :727-734